Translate this website

Immunology, infection and transplantation

We are developing an institute for immunity, infection and transplantation, with the full support of our academic partners University College London (UCL). The first phase was officially opened by His Royal Highness The Duke of York, KG, in June 2013. Phase two, which would see the development of a standalone building adjacent to the Royal Free to house further treatment facilities, laboratories and researchers is due to be completed in summer 2017.

With an adjacent clinical trials unit, the new academic centre will address a wide range of human diseases including blood and other cancers, HIV and hepatitis, autoimmune diseases, genetic diseases and the processes of ageing. It will build on cutting-edge technologies, including cell and gene therapies, next generation vaccines and new diagnostic methods. The aim is to ensure research is translated faster into new treatments for patients.

The institute will aim to:

  • Professor Margaret Johnson Create a modern and well-equipped facility which allows highly-skilled research teams to develop innovative treatments which will hugely improve the effectiveness of treatments and patient care.
  • Provide more opportunities for research teams to have contact with, and learn from, patients.
  • Attract and retain world-class people, creating teams of experts who can work together in an internationally-renowned scientific and clinical community.
  • Improve treatment and control of infectious diseases, especially for patients with a compromised immune system.
  • Explore cell and gene therapy to find new solutions for chronic infections, cancer, immune-deficiency, autoimmunity, transplant rejection and vaccinations.

There is a dedicated website for the institute: http://www.ucl.ac.uk/immunity-transplantation